NewslettersCancer Stem Cell News WDR5 Represents a Therapeutically Exploitable Target for Cancer Stem Cells in Glioblastoma By Bob - February 8, 2023 0 In glioblastomas CSCs, WDR5 inhibitors blocked WRAD complex assembly and reduced H3K4 trimethylation and expression of genes involved in CSC-relevant oncogenic pathways. [Genes & Development] Abstract